News briefing: Gilead submits filgotinib to European regulators for UC; GW Pharmaceuticals launches PhIII trial for MS candidate made with cannabis extracts - Endpoints News
What’s next for rheumatoid arthritis and cannabis? The GrowthOp One-and-a-half million people in the United States suffer from rheumatoid arthritis (RA). In fact, The Arthritis Foundation estimates that three times as many ...
Comments
Post a Comment